Stockwinners Market Radar for September 28, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:15 EDT Cathie Wood's ARK Investment bought 56.7K shares of Markforged today

18:47 EDT Fund 1 Investment discloses 9.98% stake in Citi Trends - In a regulatory 13-D filing, Fund 1 Investment disclosed a 9.98% activist stake in Citi Trends. The firm "believes that there are both operational and strategic opportunities to maximize stockholder value at the Issuer, and may choose to engage in discussions with the Issuer's management and Board of Directors, or others regarding matters related to the Issuer." Shares of Citi Trends are up 4.9% afterhours at $22.00.

18:41 EDT Provident Financial board authorizes repurchase of up to 5% of common stock - Provident Financial Holdings announced that the company's Board of Directors authorized the repurchase of up to 5% of the company's common stock, approximately 350,353 shares. The company will purchase the shares from time to time in the open market or through privately negotiated transactions over a one-year period depending on market conditions, the capital requirements of the company, and available cash that can be allocated to the stock repurchase program, among other considerations. Additionally, the April 2022 stock repurchase program which was extended on April 27, 2023 is canceled effective September 28, 2023. There were 25,428 remaining shares eligible for repurchase in the April 2022 stock repurchase program that will no longer be repurchased.

17:35 EDT Sportsman's Warehouse director buys $190K in common stock - In a regulatory filing, Sportsman's Warehouse disclosed that its director Steven Sansom bought 50K shares of common stock on September 27th in a total transaction size of $190K. Shares of Sportsman's Warehouse are up 4% afterhours at $4.25.

17:30 EDT RTX awarded $305.61M Navy contract - Raytheon was awarded a $305.61M fixed-price incentive, cost-plus-incentive-fee advanced acquisition contract. This contract procures long-lead time materials for the low-rate initial production Lot 18 F135 propulsion systems for the F-35 Lightning II Joint Strike Fighter aircraft in support of the Navy, Air Force, Marine Corps, Foreign Military Sales, or FMS, customers, and non-U.S. Department of Defense, or DOD, participants. Work is expected to be completed in July 2026. FY23 aircraft procurement funds in the amount of $63.76M; FY23 aircraft procurement funds in the amount of $39.3M; FMS customer funds in the amount of $177.07M and non-U.S. DOD participant funds in the amount of $25.49M, will be obligated at the time of award, none of which will expire at the end of the current fiscal year. This contract was not competitively procured pursuant to 10 U.S. Code 3204. Naval Air Systems is the contracting activity.

17:28 EDT Vestis to replace Kohl's in S&P 400 at open on 10/2 - Aramark (ARMK) is spinning off Vestis (VSTS) in a transaction expected to be completed on October 2. Following the spin-off, the parent Aramark will remain in the S&P MidCap 400.

17:25 EDT WK Kellogg to replace American Vanguard in S&P 600 at open on 10/3 - Kellogg (K) is spinning off WK Kellogg (KLG) in a transaction expected to be completed on October 2. Following the spin-off, the parent Kellogg will have a name change to Kellanova and will remain in the S&P 500.

17:21 EDT Cal-Maine Foods to acquire egg production assets from Fassio Egg Farms - Cal-Maine Foods announced a definitive agreement to acquire substantially all the assets of Fassio Egg Farms, related to its commercial shell egg production and processing business. The assets to be acquired, subject to the completion of this transaction, include commercial shell egg production and processing facilities with current capacity of approximately 1.2M laying hens, primarily cage-free, feed mill, pullets, fertilizer production and composting operation and land located in Erda, Utah, outside Salt Lake City. The company expects to close the transaction in the next few weeks, subject to customary closing conditions.

17:13 EDT L3Harris Technologies awarded $112.67M Army contract - L3Harris Technologies was awarded a $112.67M cost-plus-fixed-fee contract for artificial intelligence and machine learning platform research and development. Bids were solicited via the internet with one received. Work has an estimated completion date of September 28, 2028. FY23 research, development, test, and evaluation, defense-wide funds in the amount of $3.81M were obligated at the time of the award. Army Contracting Command is the contracting activity.

17:07 EDT BlackBerry reports Q2 total company non-GAAP gross margin 65% - Reports Q2 GAAP gross margin was 64%.

16:36 EDT Goodyear Tire says fire damaged portion of Debica manufacturing facility - According to a regulatory filing, Goodyear Tire said that, on August 20, 2023, a fire significantly damaged a portion of the tire curing area and caused the temporary shutdown of our tire manufacturing facility in Debica, Poland. Tire production at Debica resumed on August 22, 2023 at approximately 55% of capacity. The facility is currently operating at approximately 70% of capacity and a full ramp-up is not expected until the fourth quarter of 2024 due to the lead time to replace the damaged equipment. "We are mitigating the impact on our customers by leveraging existing inventory and by increasing production at other facilities, which should help to offset lost production until Debica returns to full production," the company said. "Europe, Middle East and Africa consumer sales are expected to be negatively impacted by $20M to $25M in the third quarter of 2023 and $10M to $15M in the fourth quarter of 2023 due to the shutdown and limited production capacity at Debica. The related lost sales margin, as well as unabsorbed fixed costs and other period expenses, resulting from the shut-down and subsequent ramp-up period are expected to negatively impact EMEA's operating income by $10M to $15M in both the third quarter of 2023 and the fourth quarter of 2023. We will provide an estimated impact to 2024 after we have confirmed the restoration schedule. We maintain third-party insurance with a $15M per occurrence deductible that covers property damage, cleanup expenses and qualifying business interruption impacts. We will reach the deductible limit and expense $15M in the third quarter of 2023 related to property damage and clean-up expenses. We expect that a significant portion of the business interruption impacts will be reimbursed by our insurance. However, due to uncertainty in determining the ultimate amount and timing of business interruption coverage that could be available to us, we did not reflect potential insurance reimbursement for business interruption in the above sales and operating income estimates for EMEA nor have we recognized a business interruption insurance receivable at this time. Consistent with past practice, we will record a receivable related to business interruption insurance once the claim is substantially complete."

16:35 EDT Jin Medical receives noncompliance notification from Nasdaq - Jin Medical received a written notification letter from Nasdaq, notifying the company that it no longer complies with the requirement of minimum 300 public holders for continued listing as set forth under Nasdaq Listing Rule 5550.

16:33 EDT AIG names Patricia Walsh as EVP and General Counsel - American International Group announced that Patricia Walsh will join AIG as Executive Vice President and General Counsel, effective December 1, 2023. Walsh will report to Peter Zaffino, AIG Chairman & CEO, and serve on AIG's Executive Leadership Team.

16:32 EDT Nyxoah partnering with ResMed in Germany - Nyxoah has entered into a partnership with ResMed Germany to increase OSA awareness and therapy penetration in the German market. Nyxoah and ResMed Germany will establish a continuum of care that will educate and guide OSA patients in the German market from diagnosis through treatment. Together, the companies will work to accelerate patient identification and better support patient set-up on the appropriate therapy. The companies will collaborate on OSA helplines and direct-to-consumer marketing initiatives, sales and marketing efforts targeting ENTs and sleep physicians and patient and clinician educational programs and symposiums.

16:31 EDT GrafTech CEO Marcel Kessler to step down - GrafTech announced that Marcel Kessler has informed the Company's Board of Directors of his intention, due to family reasons, to (i) step down as CEO and President effective November 15, 2023 and (ii) resign as an employee of the Company effective December 31, 2023. Mr. Kessler will continue to serve on GrafTech's Board. The Board has appointed Timothy K. Flanagan, the current Chief Financial Officer, Senior Vice President Finance and Treasurer of the Company, to serve as interim Chief Executive Officer and President, and Catherine Hedoux-Delgado, the current Vice President, Corporate Controller of the Company, to serve as interim Chief Financial Officer and Treasurer, each effective November 15, 2023.

16:20 EDT Astra Space cures bid price deficiency, regains Nasdaq compliance - Astra Space announced it has received notice from the Nasdaq Capital Market on September 28, 2023, that the company has regained compliance with Nasdaq's minimum bid price requirement.

16:19 EDT Better Therapeutics completes enrollment of 1,000 participates in two studies - Better Therapeutics announced it has completed the enrollment of 1,000 participants across two studies as part of its ongoing clinical program to evaluate the long-term effectiveness of AspyreRx. AspyreRx received FDA authorization in July 2023 as the first PDT to deliver Cognitive Behavioral Therapy to treat adults with type 2 diabetes. Better Therapeutics' ongoing clinical studies are designed to assess the long-term effectiveness of AspyreRx in diverse populations, as measured by change in HbA1c, and safety, as measured by severity and frequency of adverse events. The impact on medication use and healthcare utilization one year after beginning treatment with AspyreRx will also be evaluated, along with an advanced understanding of patient engagement patterns in a real-world setting. In addition, these studies intend to inform the durability of this digital therapeutic intervention. Participants have been enrolled across Colorado Prevention Center, affiliated with the University of Colorado Anschutz Medical Campus, the Durham Veterans Association Health Care System, Ascension DePaul, and Mass General Brigham. All enrolled participants have been randomized and on-boarded onto AspyreRx or a control app.

16:18 EDT Penske Automotive reports hail damage in Round Rock, Texas, dealerships - Penske Automotive announced that severe storms at its Genesis, Honda, Hyundai, and Toyota dealerships located in Round Rock, Texas, disrupted operations and caused significant hail damage to over 750 new, used and customer service loaner vehicles. The company estimates these vehicles represent over $27M in inventory value. Most of the damaged vehicles are not repairable and are anticipated to be total losses. The company is assessing the damage caused by these severe storms to determine their financial impact. Although a portion of the damage is expected to be covered by insurance, the company will incur the potential loss of new and used vehicles sales and will be responsible for its insurance deductibles.

16:17 EDT JFrog names Ed Grabscheid CFO - JFrog announced the promotion of Ed Grabscheid to the position of Chief Financial Officer, effective January 1, 2024. Joining the leadership team, Mr. Grabscheid will succeed CFO Jacob Shulman, who is leaving JFrog to pursue another opportunity and may remain in an advisory role. "I'm thrilled to welcome Ed as our new CFO. He is a seasoned finance leader who has been integral to the execution of our long-term growth strategy," said Shlomi Ben Haim, Co-Founder and CEO, JFrog. "Ed's extensive financial experience and valuable knowledge of our company, coupled with his leadership experience as a former CFO, I have no doubt he'll continue to be successful while ensuring JFrog continues to execute on our business strategy to deliver long term value to shareholders."

16:17 EDT Nike reports Q1-end inventories $8.7B, down 10% y/y - Revenues for the NIKE Brand were $12.4 billion, up 3 percent on a reported and currency-neutral basis, led by currency-neutral growth in EMEA, Greater China and APLA, partially offset by a decline in North America. Revenues for Converse were $588 million, down 9 percent on a reported and currency-neutral basis, due to a decline in North America, partially offset by growth in Asia.

16:16 EDT Nike reports Q1 Direct sales $5.4B, up 6% y/y - Inventories for NIKE, Inc. were $8.7 billion, down 10 percent compared to the prior year, primarily driven by a decrease in units, partially offset by product mix and higher product input costs. Matthew Friend, Executive Vice President & Chief Financial Officer, NIKE, Inc. said, "Our first-quarter results demonstrated the impact of staying on the offense over the past fiscal year. With a healthy marketplace and another quarter of brand and business momentum, we are strengthening our foundation for sustainable, profitable, long-term growth."

16:11 EDT Vail Resorts sees FY24 net income ($197M)-($178M) - Sees FY24 reported EBITDA ($150K)-($134K).

16:07 EDT Pennsylvania American Water reaches deal to acquire Appalachian Utilities - Pennsylvania American Water announced today that an agreement has been reached for it to acquire Appalachian Utilities, Inc. Under the terms of the transaction, an affiliate of Pennsylvania American Water will merge with Appalachian and, subsequently, Appalachian will merge into Pennsylvania American Water. Appalachian is a private, investor-owned system serving approximately 1,450 customers in Avis Borough, Pine Creek Township, and Dunnstable Township, Clinton County, and is located near Pennsylvania American Water's existing Milton, Nittany, and Boggs water systems. "Appalachian has served our customers proudly since 1995, and we are grateful for our partnership with the community over this time," explained Frank Sargent, Jr., president of Appalachian. "We believe that this transaction with Pennsylvania American Water will ensure that our customers and employees are placed in the hands of another competent, community-minded utility partner going forward." As part of the agreement, Pennsylvania American Water plans to invest more than $6.5M into the system to upgrade aging water infrastructure. "We look forward to becoming the water service provider for these customers in Clinton County, and we appreciate that the leadership at Appalachian Utilities, Inc. is entrusting us with this privilege," said Pennsylvania American Water President Justin Ladner. "The system upgrades we plan to make will benefit area customers, and the acquisition will further promote regionalization and consolidation of our central Pennsylvania systems."

16:06 EDT Quince Therapeutics says FDA lifts partical clinical hold on EryDel's EryDex IND - Quince Therapeutics announced that the U.S. Food and Drug Administration has lifted the partial clinical hold on EryDel S.p.A's Investigational New Drug application for its lead Phase 3 asset, EryDex. Pending the closing of Quince's acquisition of EryDel, Quince intends to advance the global Phase 3 NEAT clinical trial evaluating the safety and efficacy of EryDex for the potential treatment of a rare, fatal pediatric neurological disease, Ataxia-Telangiectasia. Currently, there are no approved treatments for patients with A-T and the market represents a $1+ billion estimated peak sales opportunity. Dirk Thye, M.D., Quince's Chief Executive Officer, said, "We are pleased with the FDA's decision to lift the partial clinical hold related to EryDel's lead asset, EryDex. We look forward to completing the clinical and regulatory activities necessary to advance EryDex into the Phase 3 NEAT study - with patient enrollment beginning as soon as the second quarter of 2024. Notably, this pivotal trial will be conducted under a Special Protocol Assessment (SPA) that has already been reviewed with the FDA, which should allow for the submission of a New Drug Application (NDA) following completion of this single study, assuming positive results." Quince's acquisition of EryDel is subject to certain regulatory approvals, including the foreign direct investment screening clearance in Italy, and other closing conditions and is expected to close in the fourth quarter of 2023.

16:05 EDT Stifel Financial reports August total client assets $424.94B, up 10% - Reports August fee-based clients $156.36B, up 8%. Reports August private client group fee-based client assets 137.25B, up 8%. Reports August net bank loans $20.4B, down 2%. Reports August client money market and insured product $25.48B, down 3%. Ronald Kruszewski, chairman and CEO, said, "Client cash increased by 2% in August as incremental deposits into our Smart Rate program increased, while cash sorting activity remained subdued. Additionally, Sweep and Smart Rate balances in September have increased from end of August levels. We continued to see strong financial advisor recruiting in August, which helped to partially offset the impact of lower equity markets on total client assets. In our institutional business, investment banking pipelines are improving but market conditions have delayed both deal announcements and closings."

16:01 EDT LZM Stock trading resumes

16:00 EDT LZM Stock trading halted, volatility trading pause

15:46 EDT Jaguar Global Growth Corporation I trading resumes

14:17 EDT Verastem presents avutometinib and defactinib combination program updates - Verastem Oncology announced the presentation of scientific background and clinical trial updates on the avutometinib and defactinib programs at the 5th Annual RAS-Targeted Drug Development Summit in Boston, Massachusetts. The updates are part of two oral presentations by Jonathan Pachter, PhD, Chief Scientific Officer and Louis Denis, MD, Chief Medical Officer at Verastem Oncology. The clinical presentation includes updated FRAME study efficacy data showing an overall response rate, or ORR, of 42% in evaluable patients with low grade serous ovarian cancer, or LGSOC. Among patients with KRAS mutant LGSOC, the ORR was 58%, compared to patients with KRAS wild-type LGSOC, the ORR was 33%. Across all LGSOC patients, the median duration of response was 26.9 months while median progression free survival, or PFS, was 20.0 months. As of the July 2023 data cutoff date, 19% of patients were still on study treatment with a minimum follow-up of 17 months. "We are encouraged that the high rate and long duration of objective responses in the recurrent LGSOC cohort of the FRAME study continue to provide foundational proof-of-concept supporting Breakthrough Therapy Designation for the combination of avutometinib and defactinib," said Dan Paterson, President and CEO of Verastem Oncology.

13:05 EDT Knightscope receives two K5 expansion contracts for casinos - Knightscope announces that two additional contracts for its K5 Autonomous Security Robot have been executed as part of a larger master agreement announced earlier this week. Casinos in Shreveport and Bossier City, Louisiana, will each get a K5 and are the first ASR contracts in the State. These two new ASRs bring the total robots under contract to 5, which include deployments in Las Vegas, Nevada; Council Bluffs, Iowa; and Aurora, Illinois. Knightscope ASRs at each location greet guests with a friendly voice while also providing additional eyes and ears for the large human security team. Robots also offer a two-way communication system to enhance the safety of visitors and workers.

13:01 EDT EVgo announces new fast charging collaboration with American Honda Motor - EVgo (EVGO) announced a new collaboration with American Honda Motor (HMC) that is designed to provide a range of new benefits for Honda and Acura EV drivers, including charging credit, technology integration into the HondaLink and Acura EV apps, and access to EVgo's nationwide network and its roaming partners. Drivers of qualifying Honda and Acura EV models will be eligible to receive up to $750 in charging credit to use at EVgo chargers around the country, the company stated. "This summer, Honda announced that beginning in 2025, the automaker will incorporate the North American Charging Standard, or NACS, into new EV models. Earlier this year, EVgo announced it will add NACS connectors to its fast chargers across the country-helping to ensure that its network will remain well-positioned to support drivers of all EV models for years to come," the company added.

12:26 EDT Workday, ADP expand partnership for enhanced global payroll, compliance, HR - Workday (WDAY) and ADP (ADP) announced an extended partnership to provide an enhanced frictionless global payroll, compliance, and HR experience for joint customers. Announced at Workday's annual customer conference, Workday Rising, the extended partnership builds on a decade-long relationship between the two companies and aims to enable a more streamlined experience for payroll administrators, and a better experience for joint customers overall. The companies will partner to create more seamless interactions between Workday and ADP systems to enable deeper customer visibility into data across their HCM environment including compliance, tax, and payroll.

12:17 EDT nCino rallies 6% to $31.14 after issuing long-term targets at investor day

12:06 EDT Ionis reports Phase 3 eplontersen study results published in JAMA - Ionis Pharmaceuticals announced that The Journal of the American Medical Association, or JAMA, published "positive" results from the Phase 3 NEURO-TTRansform study of eplontersen, an investigational treatment for hereditary transthyretin-mediated amyloid polyneuropathy, or ATTRv-PN. Results from the week 66 primary analysis showed that eplontersen-treated patients demonstrated improvement across all co-primary and secondary endpoints, including serum transthyretin concentration, neuropathy impairment and quality of life, compared to the external placebo group. An end-of-treatment analysis also showed eplontersen continued to demonstrate sustained improvements through 85 weeks. "These data reinforce the ability of eplontersen to halt disease progression and improve quality of life throughout the 19-month treatment period. We look forward to the upcoming FDA action date in December and bringing eplontersen to this underserved patient community in the U.S. and around the world," said Eugene Schneider, M.D., executive vice president and chief clinical development and operations officer for Ionis.

12:00 EDT Worthington falls -12.5% - Worthington is down -12.5%, or -$8.91 to $62.17.

12:00 EDT NextEra Energy Partners falls -16.6% - NextEra Energy Partners is down -16.6%, or -$6.22 to $31.24.

12:00 EDT Jabil rises 14.3% - Jabil is up 14.3%, or $15.06 to $120.24.

11:59 EDT Scisparc Ltd trading resumes

11:24 EDT IonQ announces $25.5M quantum deal with Air Force Research Lab - IonQ announced an expanded relationship with the Air Force Research Lab worth $25.5M to deploy two barium-based trapped ion quantum computing systems for quantum networking research and application development. In Q2, IonQ said it achieved $28M in bookings. "The deal also comes on the heels of a contract IonQ signed with Switzerland-based QuantumBasel to establish a European quantum data center," it added.

11:17 EDT Synlogic announces publication of Synpheny-1 Phase 2 study results - Synlogic announced the publication of results from its Synpheny-1 Phase 2 study of its drug candidates, labafenogene marselecobac and SYNB1618 in patients with phenylketonuria in the journal Nature Metabolism. The publication, entitled "Efficacy and Safety of a Synthetic Biotic for Treatment of Phenylketonuria: a Phase 2 Clinical Trial" is now available online at https://www.nature.com/articles/s42255-023-00897-6. The paper includes a comprehensive review of the data, showing clinically meaningful, dose-dependent reductions in plasma phenylalanine. "These positive results build on a body of data supporting the role of labafenogene marselecobac for patients with PKU," said Dr. Neal Sondheimer, Head of Clinical Development at Synlogic. "These findings re-enforce our urgency to complete Synpheny-3, the pivotal trial now underway, and advance this potential new treatment to the many patients who need it. The study was completed with the participation of clinical teams at University of Pittsburgh, Mount Sinai Hospital, Washington University, Oregon Health & Science University, University of Texas-Houston, Vanderbilt University, University of Colorado and University of Florida.

11:14 EDT Erayak Power Solution in discussions with potential strategic partners - Erayak Power Solution Group announced that the Company is discussing with potential strategic partners to expand its market opportunities and product reach. One of the potential partners is a diversified energy company that produces and markets fuels, natural gases, and electricity. The company has been established in China for nearly 40 years and is actively involved in the entire Chinese energy industry supply chain, from both upstream to downstream operations. Erayak is looking to share experience, technology, and industry expertise to create mutually beneficial partnerships to develop domestic and international energy solution businesses. Recently, a representative from the aforementioned company visited Erayak to gather a comprehensive understanding about the application and performance of Erayak's product lines, including inverter generator series, inverter series, household energy solutions, and storage systems. Erayak is also discussing with another potential partner, a large trading company, which serves as an authorized agency and franchisee in the UK for large brands such as Stanley Black and Decker, and IMPAX Tooling Solutions, that produce electric power tools. The company is well known and recognized within the industry for its strong sales and large product shipment abilities. This potential collaboration would allow both companies to produce more electrically powered clean energy products.

11:05 EDT Spirit Airlines announces self-bag drop debut at DTW - Spirit Airlines is now offering Guests in the Motor City a speedy, self-service option to breeze through check-in. The carrier has introduced its award-winning self-bag drop with biometric photo-matching at Detroit Metropolitan Wayne County Airport. Spirit leads the way as the first airline to roll out this innovative technology at DTW. The six newly installed self-bag drop units are located next to the Spirit ticket counter in the Evans Terminal and were added through a partnership with the Wayne County Airport Authority. Self-bag drop allows Guests to check bags directly without working with an agent. Spirit's machines are also equipped with biometric photo-matching capability that compares a scan of government-issued identification with a photo of the Guest for verification. Following an initial testing period at DTW with both manual ID check and biometric opt in, the solution will eliminate the need to hand government-issued identification to an agent when checking baggage.

11:02 EDT XFL and USFL announce intent to merge - The United States Football League, or "USFL," and the XFL announced their intention to merge. "Subject to customary regulatory approvals and if the transaction is consummated, the new league will establish best-in-class operations based on the most recent seasons of both leagues. This historic combination will anchor professional spring football with substantial capabilities and resources to ensure future growth and continue to enhance the development of the collective players, coaches, and staff that are coming together. More details regarding the new league will be announced at a later date," the leagues stated in a press release. Fox Sports (FOXA) and NBC Sports (CMCSA) are official media partners of the USFL, presenting all 43 regular- and postseason games for the eight-team league. The XFL, which also has eight teams, is owned by Dany Garcia, Dwayne Johnson, and Gerry Cardinale's RedBird Capital Partners and launched in February 2023.

10:43 EDT Amicus announces FDA approval of Pombiliti plus Opfolda - Amicus Therapeutics announced that the U.S. Food and Drug Administration has approved Pombiliti + Opfolda 65mg capsules. This two-component therapy is indicated for adults living with late-onset Pompe disease weighing greater than or equal to 40 kg and who are not improving on their current enzyme replacement therapy, or ERT, the company stated. Amicus Therapeutics will launch Pombiliti + Opfolda immediately in the U.S. The FDA previously granted Breakthrough Therapy designation for Pombiliti + Opfolda. Pombiliti + Opfolda has also been approved for the treatment of adults with LOPD in the European Union and the United Kingdom, the company noted.

10:28 EDT IntercontinentalExchange sees $200M expense synergies at Black Knight by year 5 - IntercontinentalExchange CFO Warren Gardiner said on a call to discuss the acquisition of Black Knight by Intercontinental Exchange: "Based on a closing date of September 5, we expect that Black Knight will contribute approximately $85M to $90M of net revenues and roughly $50M to $55M of adjusted operating expenses to our third quarter results... We intend to provide you with historical pro forma results in early October and additional guidance respect to our - with respect to our 2024 expectations on our fourth quarter earnings call in early February... Moving to expense synergies. We continue to expect approximately $200M by year five with $100M and run rate synergies realized by the end of 2024, $150M by the end of year three and $200M by year five... It's worth noting that following the close, we have already identified approximately $40M of annualized savings, giving us increased comfort in our ability to achieve our $200M target."

10:25 EDT SHENGFENG DEVELOPMENT Ltd trading resumes

10:14 EDT Axcella Health trading resumes

10:10 EDT Norfolk Southern appoints Will Miller as director of public engagement - Norfolk Southern Corporation announced a new role focused solely on collaborating with the communities it serves. Norfolk Southern's Director Public Engagement will help marshal resources to improve railroad infrastructure and engagement with local leaders and their citizens. As the newly appointed Director Public Engagement, Will Miller, will lead a cross-departmental team to identify solutions and then coordinate and monitor their implementation. Miller has been with Norfolk Southern for more than 17 years. Most recently, he served as Public Safety Director and began his career as a Conductor Trainee.

10:09 EDT Axcella Health trading halted, volatility trading pause

10:05 EDT Upstart down 1% to $26.61 after Bleecker Street short report

10:03 EDT Hyatt plans short-term vacation rental platform Homes & Hideaways - Hyatt Hotels Corporation announced plans for a new short-term vacation rental platform, Homes & Hideaways by World of Hyatt, that will feature private homes and remote hideaways in the United States. When the offering launches, which is expected in the coming weeks, World of Hyatt members will have direct booking access to a unique collection of short-term private home rentals from beachfront escapes to mountainside ski chalets, where they can earn and redeem points beyond the traditional hotel stay. The planned launch of Homes & Hideaways by World of Hyatt reinforces Hyatt's commitment to providing more flexible stay experiences to suit the travel needs of every guest. The focus on the premium vacation rentals segment will allow members to unlock access to residential rental accommodations across the United States in key travel destinations like Hawaii, Colorado, and more, with plans to grow the platform globally. Leading up to the launch of Homes & Hideaways by World of Hyatt, Hyatt has identified a highly qualified company, Lowe, that, through an affiliate, will purchase and operate the existing vacation rental management business that is currently branded Destination Residences Management.

10:00 EDT Worthington falls -10.5% - Worthington is down -10.5%, or -$7.47 to $63.61.

10:00 EDT Suburban Propane rises 10.2% - Suburban Propane is up 10.2%, or $1.50 to $16.17.

10:00 EDT Chico's rises 62.1% - Chico's is up 62.1%, or $2.87 to $7.47.

09:57 EDT Desktop Metal says 'focused on path to profitability,' Stratasys deal terminated - Desktop Metal (DM) announced that its stockholders approved the merger agreement with Stratasys (SSYS). However, at a special meeting of Stratasys stockholders on Sept. 28, Stratasys announced that a preliminary tally indicated that it did not obtain stockholder approval for the proposals related to the merger agreement. Consequently, the previously announced merger agreement has been terminated and DM is to be compensated agreed-upon fees. "We're grateful for our shareholders' support. While the team at Desktop Metal believed in the merits of our combination, and is disappointed in the outcome of the merger agreement, we are completely confident in the trajectory of our business, which continues to lower operating costs while growing revenue. Our plan to reduce costs and generate revenue remains on track as customers continue transitioning to our AM 2.0 technologies for mass production of metal, polymer, ceramic and health products," said Ric Fulop, Founder and CEO of Desktop Metal. "Desktop Metal entered the second half with cash of $127.6M, and has demonstrated improvements to operating cash management over multiple quarters," the company added.

09:47 EDT Sunlands Online falls -6.5% - Sunlands Online is down -6.5%, or -36c to $5.12.

09:47 EDT CarMax falls -10.0% - CarMax is down -10.0%, or -$7.98 to $71.71.

09:47 EDT Jabil rises 6.8% - Jabil is up 6.8%, or $7.12 to $112.30.

09:46 EDT ADiTx Therapeutics trading halted, volatility trading pause

09:33 EDT Peloton enters multi-year partnership with New York Road Runners - Starting with the TCS New York City Marathon, New York Road Runners and Peloton have announced a multi-year partnership to bring NYRR races to life to runners around the world through Peloton Scenic and Outdoor content. The audio classes will release in late 2023 with Scenic content launching in the spring of 2024 on the Peloton Tread/Tread+. Peloton will be a Strategic Partner of NYRR's through 2025 in the Digital Fitness category, as the brands work together to create motivational fitness content accessible to runners of all abilities. As a new Strategic Partner, Peloton will also activate around the United Airlines NYC Half and the RBC Brooklyn Half.

09:28 EDT Xponential Fitness, Lululemon confirm ongoing retail partnership - Lululemon (LULU) and Xponential Fitness (XPOF) issued the following statement regarding their ongoing retail partnership: "Xponential Fitness has been a valued partner since we announced our lululemon Studio collaboration in October 2022, and we look forward to continuing to grow and invest in our joint retail partnership with them," said Celeste Burgoyne, President, Americas and Global Guest Innovation, lululemon. "While lululemon will strategically move away from providing all partner content on lululemon Studio after October 31, 2023, we very much look forward to continuing partnering with Xponential Fitness and their local studios around the world."

09:26 EDT Ideal Power adds SymCool IQ to commercial product offerings - Ideal Power announced the launch of its second commercial product, the SymCool IQ Intelligent Power Module. SymCool IQ builds on the bidirectional B-TRAN multi-die packaging design of our SymCool power module and adds an integrated intelligent driver optimized for bidirectional operation.

09:21 EDT NaaS and parent NewLink partner with China Construction Bank - NaaS Technology's parent company, NewLink, an energy IoT solution provider and China's largest digital energy asset operator, has partnered with China Construction Bank - CCB -. CCB will provide NewLink and Naas Technology with integrated financial services support. The partnership will encompass various financial areas, including global new energy asset investment and construction finance, supply chain finance, financial inclusion, energy scenario payment and settlement, energy digital accounts, investment banking services, domestic and foreign M&A financial support, traditional financing and credit, asset management services, consumer finance, and more. NaaS will give full play to the energy asset presence it has built both at home and abroad, including equity M&A and new energy asset investment and construction. CCB, in turn, will leverage NewLink and NaaS' digital analytics capabilities and investment decision-making algorithm analysis models of its global new energy assets. Both parties will collaborate to create a green finance model that supports the industry's low-carbon development.

09:20 EDT Correction: Xerox to buy back shares from Icahn for $15.84 per share

09:18 EDT Senmiao Technology signs cooperation agreement with auto financing company - Senmiao Technology's operating subsidiary Hunan Xixingtianxia Technology, or XXTX, through its subsidiary Chengdu Xixingtianxia, has signed a strategic cooperation agreement with Heilongjiang Kunrui Financing Guarantee, a financing services company that provides vehicle purchasing and auto insurance installment loan guarantee services to enterprises and individuals. Kunrui provides financing guarantee services for new energy vehicles used in online ride-hailing and is a financing and guarantee company incorporated in Heilongjiang Province serving automobile rental companies across the country. Kunrui will provide Senmiao with financial resources in new energy vehicle financing and auto insurance installment services. Senmiao will introduce Kunrui to its new energy vehicle dealership partners and provide access to its auto financing technologies. In addition, Senmiao and Kunrui are exploring the possibility of developing a new energy auto financing system, which could serve as a potential SaaS business opportunity for both companies.

09:18 EDT Orgenesis applauds decision by MACs to withdraw LCDs - Organogenesis Holdings applauds decision by the three Medicare Administrative Contractors to withdraw the final local coverage determinations for Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers scheduled to take effect on October 1.

09:12 EDT Greenland Technologies wins Port of Baltimore bid - Greenland has emerged as the winner in a bid from Maryland's Port of Baltimore, potentially positioning itself as a key player participating in the global shift towards electrification. The company will be instrumental in Port of Baltimore's plan to electrify its port equipment. A significant component of this plan involves the integration of Greenland's cutting-edge GEL-5000 all-electric front loader.

09:10 EDT Hepsiburada signs contribution agreement with TurkCommerce - D-MARKET Electronic Services & Trading d/b/a "Hepsiburada" has signed a contribution agreement with TurkCommerce B.V. pursuant to which the Company has agreed to purchase 4,615,384 Class B ordinary shares of the Company from TurkCommerce against payment of $5,732,306.93, corresponding to a purchase price per share of $1.242. The price per share represents a discount of 10% over the official closing price on Nasdaq of one Hepsiburada American Depositary Share on September 27, 2023. The Share Purchase Price will be paid by way of a combination of off-setting the $3,975,000 settlement contribution amount owed by TurkCommerce to Hepsiburada under the term sheet entered into between the parties in December 2022 pursuant to which TurkCommerce agreed to contribute the Contribution Amount towards the settlement of the two class action lawsuits filed before the Supreme Court of the State of New York, County of New York and the United States District Court, Southern District of New York, respectively, and a $1,757,306.93 cash payment on the date of closing of the Transaction. The closing of the Transaction is expected to occur on or around October 12, 2023. The Company is expected to use the Class B ordinary shares purchased in this Transaction for the purpose of delivering Class B ordinary shares under the Company's Revised Incentive Plan adopted by the Board of Directors on April 24, 2023.

09:08 EDT Ace Global Business Acquisition extends period for initial business combination - Ace Global Business Acquisition announced that Ace Global Investment, the company's initial public offering sponsor, has deposited into the company's trust account an aggregate of $98,858.95 representing, approximately 5c per ordinary share, in order to extend the period of time the company has to complete a business combination for an additional one month period, from October 9 to November 8. The company issued a promissory note to the Sponsor with a principal amount equal to the amount deposited. The promissory note bears no interest and is convertible into the company's units at a price of $10.00 per unit at the closing of a business combination by the company. The purpose of the extension is to provide time for the company to complete a business combination.

09:07 EDT EnWave signs equipment purchase agreement with BranchOut Food - EnWave Corporation (NWVCF) announced that it has signed an Equipment Purchase Agreement with BranchOut Foods (BOF), an international food-tech company dedicated to bringing extraordinary natural snacks and real superfood ingredients to market. BranchOut has been a licensed royalty partner of EnWave's for several years and currently operates 10kW and 60kW Radiant Energy Vacuum dehydration machinery, the Company's proprietary technology, to produce a portfolio of fruit and vegetable products. The Agreement provides for the acquisition of a 120kW REV machine, which is anticipated to be delivered to BranchOut in late calendar 2024 pursuant to build-out plans. BranchOut has paid an initial non-refundable deposit and is obligated to make several additional non-refundable payments through fiscal 2024. Subject to this REV machinery purchase, BranchOut and EnWave have agreed to certain additional exclusive production rights to further protect the commercial efforts of BranchOut.

09:05 EDT Fortinet joins the United Nations Global Compact - Fortinet announced that it has joined the United Nations Global Compact, UNGC, initiative, a voluntary leadership platform for the development, implementation, and disclosure of responsible business practices. Barbara Maigret, SVP, Global Head of Sustainability at Fortinet said, "Addressing societal challenges such as climate change, the rise of cybercrime, and the long-term impacts of the pandemic require engagement and collaboration between the private sector, NGOs, and governments. Fortinet is committed to doing its part in contributing to just, safe and sustainable societies. As a testament to our commitment, we are delighted to be members of the United Nations Global Compact, standing alongside thousands of leaders worldwide. We openly pledge to drive sustainable business practices in accordance with the UNGC's Ten Principles and to support the United Nations Sustainable Development Goals."

09:04 EDT LegalZoom announces the beta launch of Doc Assist - LegalZoom announced the beta launch of Doc Assist, a free document summarization product combining the power of generative AI and LegalZoom's expertise in legal tech to help small businesses quickly review documents, stay organized, grasp core details swiftly and effectively, and gain access to expertise from vetted attorneys to make more informed decisions. "Every small business should be able to understand the contracts it signs or sends for signature. Generative AI is an important component, but it's best coupled with a credentialed attorney who is well versed in the type of legal document in question. LegalZoom is in a unique position to provide access to both," said Dan Wernikoff, LegalZoom's CEO.

09:04 EDT Allegiant Travel CEO John Redmond resigns, former CEO Gallagher to succeed - Allegiant Travel announced that John Redmond has resigned as CEO and as a member of the Board of Directors effective immediately. Maurice Gallagher, former CEO, current executive chairman and one of the company's largest stockholders, will resume the CEO role. Gallagher will also maintain his role as chairman of Allegiant's board. Anderson was appointed president of Allegiant in 2022. Since joining the company in 2010, he has held several leadership roles, including senior vice president - treasury, principal accounting officer, and CFO. Prior to joining Allegiant, he worked in corporate accounting for U.S. Airways.

09:03 EDT Stratasys initiates process to explore strategic alternatives - Stratasys (SSYS) announced that its board of directors has initiated a process to explore strategic alternatives for the company. This decision follows its announcement that, based on its preliminary count of the votes cast at the company's extraordinary general meeting of shareholders, Stratasys shareholders did not approve the terms of the previously announced merger agreement with Desktop Metal (DM) dated May 25. Accordingly, Stratasys has terminated the merger agreement. The final, certified voting results for the Stratasys EGM will be provided in a Form 6-K to be furnished to the U.S. Securities and Exchange Commission, which Stratasys expects to occur within four business days. The process will begin immediately. Potential strategic alternatives to be explored or evaluated may include, but are not limited to, a strategic transaction, potential merger, business combination or sale.

09:02 EDT MGM Resorts JV signs agreement for integrated resort in Osaka, Japan - MGM Resorts International announced that Osaka IR Corporation, a joint venture with ORIX Corporation established to develop the Osaka IR Project, signed an agreement with Osaka Prefecture and Osaka City to implement the Specified Integrated Resort Facilities Area Development Plan for Yumeshima, Osaka. MGM and ORIX, together with Osaka IR Corporation, will contribute to the sustainable growth and development of tourism and the economy of Osaka and the Kansai region, as well as Japan through this first-of its-kind project in Japan.

08:58 EDT Getty Images renewed as official photographic partner of MLB - Getty Images announced a renewed partnership with Major League Baseball that sees Getty Images continue as an Official Photographic Partner of MLB. As an Official Photographic Partner, Getty Images' sport photographers and editors will deliver high-quality imagery from every MLB regular season game and dozens more Playoff and World Series games, all to be distributed exclusively on gettyimages.com.

08:51 EDT TotalEnergies finalizes acquisition of 'France's agrivoltaics leader' Ombrea - TotalEnergies announced it has finalized the acquisition of "France's agrivoltaics leader," Ombrea. "Ombrea was founded in 2016. It has built ten sites and studied around fifty crop varieties, to develop unique expertise and innovative solutions that optimize the synergies between agricultural production and green electricity generation. By integrating Ombrea's teams and expertise into its renewable activities, TotalEnergies intends to accelerate its development in agrivoltaics, both in France and abroad. Under the Ombrea brand, TotalEnergies will offer the farming community solutions for combining solar power and agricultural production, including solutions for protecting against weather events, maintaining or even improving yields, and adapting to climate change. This acquisition will also enable TotalEnergies to accelerate the development of its portfolio of 1.5 GW of agrivoltaic projects that meet the criteria set out under the French Renewable Energy Acceleration Law adopted in March 2023," TotalEnergies stated.

08:46 EDT State of Texas selects Conduent solution for Medicaid claims - Conduent has been selected by the Texas Health and Human Services Commission for Medicaid Claims processing and support. Under the multi-year contract, the company will provide claims processing and financial services via its innovative Conduent Medicaid Suite. The system will bring HHSC a seamless solution to manage Medicaid fee-for-service, long-term care and other special program claims for five million members in the state. Conduent will manage the implementation and provide ongoing support to ensure advanced system security and performance.

08:44 EDT SharpLink Gaming, SB22 partner fo AI-powered sports fan activation solutions - SharpLink Gaming and SB2 announced that the companies have joined forces to disrupt the current Event Wagering industry with a solution built specifically for U.S. sports betting and iGaming operators. The agreement calls for the full integration of SharpLink's proprietary C4 BetSense, an AI-powered audience acquisition technology, with SB22's GLI-33 Certified Fi22 sports betting platform.

08:39 EDT Paltalk engages with Cleverbridge to serve international markets - Paltalk announces its engagement of Cleverbridge, a growth engine for global technology companies. Cleverbridge's robust suite of global payment and eCommerce capabilities empowers Paltak to optimize international geographic markets while minimizing risk and administrative work. Jason Katz, Chairman and CEO of Paltalk, commented, "Cleverbridge is an ideal company for us to work with, with nearly two decades of payments' experience and excellent fraud detection. Beyond facilitating and authenticating payments, we believe Cleverbridge can help us increase our acceptance rates and reduce fraud at a global scale. Its chargeback prevention algorithms have earned it one of the highest trust scores in the payment processing industry. We are pleased to offer such outstanding capabilities to our current and prospective international subscribers, particularly in Europe."

08:38 EDT Nano-X Imaging announces use of HealthCCSng in clinical study of CT scans - NANO-X IMAGING announced that HealthCCSng, an AI-powered solution created by Nanox's deep-learning medical imaging analytics subsidiary, Nanox.AI, was used in a clinical study evaluating routine CT scans and found that 58% of patients unknowingly had moderate to severe levels of coronary artery calcium, a proven indicator of future cardiac events. The study was sponsored by Nanox.AI and conducted by the Beilinson Hospital, one of the largest and most renowned multidisciplinary medical institutions in Israel, and utilized Nanox.AI's HealthCCSng, an FDA-cleared and CE marked tool designed specifically for cardiac health assessment. Nanox.AI's HealthCCSng solution utilizes medical imaging data from routine chest CT scans to automatically quantify and analyze CAC category. CAC is the strongest predictor of future cardiac events, with patients in the highest category being over 20 times more likely to suffer a cardiac event. Many studies show a clear correlation between coronary artery calcium detected and severity of disease. In the study, Nanox.Al's HealthCCSng software was employed to assess Coronary Artery Calcification levels from non-gated, non-contrast chest CT scans. The software's categorizations were subjected to qualitative evaluation by two radiologists who reviewed each case. Patient categorization included low, moderate and severe with exclusions applied to individuals with certain medical histories or artifacts. Among the 326 eligible patients who participated in the study from January to July 2023, 101 out of 326 exhibited severe CAC, 88 had moderate CAC, and 137 showed low CAC. Patients with severe CAC levels were referred to specialized preventive cardiology clinics for in-depth evaluation and treatment. Those categorized with low and moderate CAC were directed to primary care physicians for further assessment and medical optimization.

08:37 EDT George Economou discloses 9.1% stake in OceanPal - Sphinx Investment Corp.,, Mayport Navigation Corp., and George Economou, disclosed holding a 9.1% stake in OceanPal in a regulatory filing, which notes that Sphinx and Maryport are both controlled by Mr. Economou. Sphinx purchased the 324,350 ommon shares reported herein for a total purchase price of $563,092 including fees and expenses, the filing stated, adding that the "Reporting Persons acquired the Common Shares over which they exercise beneficial ownership in the belief that the Common Shares are undervalued and are an attractive investment."

08:35 EDT Tellenger wins three-year contract from systems integrator - Tellenger was awarded a three-year contract by a large systems integrator to provide modernization support for a major financial program for a large U.S. Government customer. The company expects total revenues of $4M over the course of the contract's period of performance. Tellenger has been tasked to provide services to modernize a major financial system to allow for easier maintenance and greater reliability on a new platform. The effort will use new technology and products.

08:33 EDT Jaguar Global Growth I, GLAAM receive shareholder approval for combination - Jaguar Global Growth Corporation I, GLAAM, and Captivision announced that their previously announced business combination was approved by Jaguar Global's shareholders during its extraordinary general meeting of shareholders held on September 27th. Over 79% of the votes cast at the Extraordinary General Meeting were in favor of approving the business combination. Jaguar Global shareholders also voted to approve all other proposals presented during the Extraordinary General Meeting. The complete official results of the vote will be included in a current report on Form 8-K, which will be filed by Jaguar Global with the U.S. Securities and Exchange Commission. As a result of the business combination, GLAAM and Jaguar Global shareholders will exchange their shares for shares in a new combined company that is named "Captivision Inc." Captivision's ordinary shares and warrants are expected to be listed on the Nasdaq Stock Market under the proposed ticker symbols "CAPT" and "CAPTW," respectively.

08:32 EDT Amprius Technologies announces ordinance approval to make lithium-ion batteries - Amprius Technologies announced that the Brighton City Council approved an ordinance to rezone an approximately 103 acre site, including an existing 1,278,455 square foot facility, to allow, among other matters, the company to manufacture its next-generation lithium-ion batteries. This marks a significant milestone clearing the path for Amprius to establish its gigawatt-hour scale factory site to meet growing customer demand.

08:32 EDT Mawson Infrastructure appoints Ryan Costello to board of directors - Mawson Infrastructure Group announced the appointment of Mr. Ryan Costello as an independent Member of the Board of Directors and independent Member of the Audit, Compensation and Nomination and Governance Committees commencing October 2, 2023. The Audit Committee will also subsequently consist of the required number of independent directors under NASDAQ Rules. Mr. Costello previously served as U.S. Congressman from Pennsylvania from 2015-2019.

08:29 EDT Amicus trading halted, news pending

08:27 EDT Edesa Biotech publishes Phase 2 substudy results of ARDS candidate - Edesa Biotech announced the preprint publication of favorable data from a Phase 2 substudy of critically ill patients with a severe form of respiratory disease called Acute Respiratory Distress Syndrome. Approximately 10% of all intensive care admissions are ARDS related. The formal manuscript available today in preprint consists, in part, of mortality rates from critically ill patients who received mechanical ventilation plus additional organ support, including extracorporeal membrane oxygenation therapy, and who were hospitalized for SARS-CoV2-related respiratory disease during the pandemic. Among the findings, a survival analysis using Cox's Proportional Hazard Model demonstrated that patients treated with EB05 plus standard of care had an 84% reduction in the risk of dying when compared to placebo plus standard of care at 28 days. Edesa previously released summarized study results and the preprint manuscript is the first-time that the detailed data is available with supporting tables, listings, figures and references. Paridiprubart represents a new class of emerging therapies called Host-Directed Therapeutics that are designed to modulate the body's own immune response when confronted with infectious diseases or even chemical agents. Importantly, these therapies are designed to work across multiple infectious diseases and threats, and could be stockpiled preemptively ahead of outbreaks. Because they are threat agnostic, HDTs like paridiprubart have the potential to become standard of care in ICUs and critical countermeasures for both pandemic preparedness and biodefense. Based in part on these data, the company initiated a Phase 3 study, and has received a Fast Track designation from the U.S. Food and Drug Administration.

08:23 EDT Lightspeed enters preferred partnership with Joel Robuchon International - Lightspeed Commerce announces that it has entered into a preferred partnership with the Joel Robuchon International group of restaurants. "I grew up watching Joel Robuchon's cooking shows. This is incredible. It's such an honor," said JP Chauvet, Lightpseed's CEO. "Chef Robuchon built an empire. His restaurants were awarded 31 Michelin stars. It's still a world record. His whole cooking philosophy-centered on the customer-echoes Lightspeed's mission to deliver something that appears to be simple but is, in fact, incredibly complex."

08:22 EDT Rio2 Limited announces results of annual general meeting - Rio2 Limited announces the results of voting at its Annual and Special General Meeting of Shareholders held on Wednesday, September 27, 2023. A total of 119,076,933 common shares were voted, representing 46.02% of 258,753,108 shares issued and outstanding as of the record date of the meeting. Shareholders voted in favor of all items put forward by the board of directors and management. All seven of the individuals nominated for the board of directors were elected. At the Meeting shareholders also approved amendments to the Company's 2018 Rio2 Stock Option Plan. The Amended Plan is substantially the same as the 2018 Stock Option Plan; however, it allows for the exercise of stock options on a cashless and net exercise basis and contains other minor amendments to ensure compliance with TSX Venture Exchange Policy 4.4 - Security Based Compensation which was implemented by the Exchange on November 24, 2021. As a result of the shareholder approval, the 2018 Stock Option Plan will be of no further force and effect and all options and stock option agreements issued under the 2018 Stock Option Plan will be deemed to be issued under the Amended Plan and henceforth governed under the Amended Plan. At the Meeting, shareholders also voted in favor of reappointing Grant Thornton LLP as Company auditors for the ensuing year and authorizing directors to fix their remuneration.

08:20 EDT Bigg Digital Assets closes acquisition of TerraZero - BIGG Digital Assets completed the previously-announced amalgamation between TerraZero Technologies and a subsidiary of the Company, which resulted in BIGG acquiring all of the outstanding common shares and preferred shares of TerraZero. Pursuant to the Transaction, Dan Reitzik was appointed as a non-voting observer to the board of directors of the Company and will hold such position until September 28, 2024.

08:19 EDT Ardelyx announces publication of results from T3MPO-3 trial of tenapanor - Ardelyx announced the publication of results from the T3MPO-3 long-term open-label safety trial of IBSRELA for irritable bowel syndrome with constipation, IBS-C, in the Journal of Neurogastroenterology and Motility, JNM. The paper, titled "Long-term safety of tenapanor in patients with irritable bowel syndrome with constipation in the T3MPO-3 study," can be accessed in the current online edition of the publication. IBSRELA, discovered and developed by Ardelyx, has a first-in-class mechanism of action and is approved by the U.S. Food and Drug Administration to treat IBS-C in adults. In this long-term open-label safety study, tenapanor showed acceptable tolerability with a safety profile consistent with that reported in the prior studies. "The T3MPO-3 results provide important data on IBSRELA's safety profile in a longer-term setting," said David Rosenbaum, Ph.D., chief development officer of Ardelyx. "We are pleased by the publication of these results in this distinguished gastroenterology journal as we continue to grow awareness of IBSRELA as another option for people with IBS-C." Patients who completed T3MPO-1 or T3MPO-2, the two Phase 3 trials of tenapanor for IBS-C, were eligible for enrollment in T3MPO-3. The T3MPO-3 trial enrolled a total of 312 patients of which 262 patients completed treatment. Patients received open-label tenapanor 50 mg twice a day for up to an additional 39 or 26 weeks. Ninety patients received greater than or equal to52 weeks of tenapanor. Treatment-emergent adverse events were reported in 117 of the 312 patients in the entire T3MPO-3 population and in 52 of the 90patients who received greater than or equal to52 weeks of tenapanor. Overall, 10.6% of patients experienced diarrhea. TEAEs led to limited discontinuations in the entire T3MPO-3 safety population, due to diarrhea, due to flatulence and abnormal GI sounds. Tenapanor was generally well tolerated with diarrhea being the most commonly reported adverse event.

08:17 EDT Sunrun closes $715M senior securitization of residential solar, battery systems - Sunrun has closed the securitization of leases and power purchase agreements, known as Sunrun's solar-as-a-service offering, and raised additional subordinated non-recourse financing. The securitization transaction was structured with two pari passu tranches of A- rated notes and a single class of BB+ rated notes. The $440mm Class A-1 notes were marketed in a public asset backed securitization whereas the $275mm Class A-2 notes were privately placed. The Class A-1 and A-2 notes were both priced with a coupon of 6.60%. Strong investor demand for the Class A-1 notes resulted in a spread of 240bps and a yield of 6.78%, while also enabling the Class A-1 notes to be upsized by $100mm to $440mm. The spread of 240bps represents an improvement of 25bps from Sunrun's 2023-1 asset backed securitization in May 2023. The Class A-1 and A-2 notes represent an advance rate of approximately 67.4% of the securitization share of the aggregate discounted solar asset balance using a 6% discount rate. The Class A-1 and A-2 notes have an expected weighted average life of 6.53 years, an Anticipated Repayment Date of July 30, 2030 and a final maturity date of January 30, 2059. Similar to prior transactions, Sunrun raised an additional subordinated subsidiary-level non-recourse financing totaling $253mm, after the securitization transaction closed, which increased the cumulative advance rate obtained by Sunrun. The terms associated with the securitization and subsequent subordinated non-recourse financing, taken together with related tax equity proceeds, upfront incentives, and customer prepayments, net of transaction fees and required cash reserves, are equivalent to a cumulative advance rate that is consistent with the company's prior commentary of approximately 79% to 84% of the company's contracted Subscriber Value metric using a 6% discount rate. Sunrun obtained actual net proceeds that slightly exceeded this range in the most recent series of transactions, with the debt sizing benefiting from approximately a quarter of the assets in these financings being seasoned as they have been placed in service over 6 years ago. In connection with including these seasoned assets in the financing, Sunrun also repaid $255 million in total debt, including senior and subordinated term loans maturing in 2024 and 2029, respectively.

08:14 EDT Vaccinex's next-generation ActivMAB published in mAbs - Vaccinex announces a new publication in the journal mAbs describing a novel way in which its proprietary ActivMAb poxvirus platform can enable the presentation of high complexity, hard-to-drug proteins as targets for antibody discovery. The article, titled "Use of poxvirus display to select antibodies specific for complex membrane antigens" provides an overview of how Vaccinex created an elegant, poxvirus system modified for safety that can readily express high levels of hard-to-drug protein targets, such as G-protein coupled receptors and ion channels, on the natural external membrane of virus in a "native", properly-oriented conformation. "We believe this new "Antigen Virus" application is a powerful complement to Vaccinex' ActivMAb platform and we are pleased for this work to be published in mAbs. After rigorous evaluation, using a variety of different, complex protein targets including the SARS-CoV-2 Spike protein and a number of GPCRs, we believe that the ActivMAb system can readily generate functional and properly folded complex proteins that can be used for selection of novel, high-value, antibody therapeutics," said Ernest Smith, Ph.D., Senior Vice President of Research and Chief Scientific Officer of Vaccinex. This novel application of Vaccinex's ActivMAb technology was successfully used with OmniAb, Inc.'s high-throughput B cell screening and proprietary in vivo immunization platform. OmniAb was able to select antibodies against challenging multipass membrane targets, that were displayed on ActivMAb antigen viruses.

08:12 EDT TOP Ships announces 1-for-12 reverse stock split - TOP Ships has determined to effect a 1-for-12 reverse stock split of the Company's issued common shares. The Company's shareholders approved the reverse stock split and granted the Board the authority to determine the exact split ratio and when to proceed with the reverse stock split at the Company's Annual Meeting of Shareholders held on September 5, 2022. The reverse stock split is expected to take effect, and the Company's common stock will begin trading on a split-adjusted basis on the NASDAQ Capital Market, as of the opening of trading on Friday, September 29, 2023 under the existing ticker symbol "TOPS." The new CUSIP number for the Company's common stock will be Y8897Y 230. When the reverse stock split becomes effective, every 12 shares of the Company's issued and outstanding common stock will be automatically combined into one issued and outstanding share of common stock without any change in the par value per share or the total number of authorized shares. This will reduce the number of outstanding shares of the Company's common stock from approximately 20.3 million shares to approximately 1.7 million shares.

08:11 EDT NeoGames Studio launches eInstant games with Atlantic Lottery - NeoGames has significantly expanded its reach in Canada through the launch of its premium eInstant games from NeoGames Studio with Atlantic Lottery. The agreement, through NeoPollard Interactive, a company jointly owned by Pollard Banknote Limited and NeoGames S.A., and powering the most profitable iLottery programs, sees AL gain access to a rich stream of content created by NeoGames Studio. The lottery can now benefit from a portfolio of award-winning, top-performing games, in a deal that is NeoGames' first pure digital content partnership in Canada. AL and NeoGames Studio will work together on a roadmap of future games and technological enhancements.

08:09 EDT Elys Game Technology's Multigioco unveils online offerings in Italy - Elys Game Technology announced the launch of its revamped online casino and sports betting site and mobile app for its core B2C operations in Italy, through its wholly owned subsidiary, Multigioco Srl. The upgraded www.newgioco.it platform made its debut on Wednesday, September 27, 2023, featuring a visually appealing and feature-rich design, and an extensive array of offerings, including 1,600 sports betting markets and approximately 2,200 online casino games. This enhanced platform provides users with enhanced graphics and simplified, ultra-fast online registration, ensuring a seamless and enjoyable experience for both sports betting and online casino gaming enthusiasts.

08:08 EDT Microchip adds nine new solution stacks to mid-range FPGA, SoC support - The company said, "Designing systems for the intelligent edge has never been more difficult. Market windows are shrinking, the costs and risks of new designs are rising, thermal constraints and reliability are twin priorities and the need for cradle-to-grave security continues to grow. Satisfying these simultaneous demands requires immediate knowledge of special technology and vertical-market expertise. There's no time to start from scratch. Today, Microchip Technology adds nine new technology- and application-specific solution stacks to its growing collection of mid-range FPGA and System-on-Chip support. The stacks span the industrial edge, smart embedded vision and edge communications."

08:06 EDT Cocrystal Pharma doses first subjects in study of CDI-988 - Cocrystal Pharma, announces dosing of the first subjects in a Phase 1 clinical trial with its oral, first-in-class pan-norovirus and pan-coronavirus 3CL protease inhibitor CDI-988. "CDI-988 is a breakthrough discovery of the first-in-class pan-coronavirus and pan-norovirus antiviral agent with potential efficacy in these two indications and we excited to take the first step in its clinical development. Our oral antiviral candidate has the potential to save patient lives and reduce the severity of norovirus and coronavirus infections now and in future pandemic outbreaks," said Sam Lee, Ph.D., Cocrystal's President and co-CEO. "We are looking forward to advancing CDI-988 to the next stage of norovirus and coronavirus clinical development upon completion of this Phase 1 study, setting up a transformational year ahead for Cocrystal."

08:05 EDT Coffee Holding, Delta Corp announce filing of registration statement - Coffee Holding and Delta Corp Holdings announced the filing with the U.S. Securities and Exchange Commission of a registration statement on Form F-4 by Delta Corp Holdings Limited, a newly created holding company incorporated under the laws of the Cayman Islands. The registrant Pubco is also referred to as Delta Corp Holdings Limited or Delta Corp Holdings Ltd. As previously announced, on September 30, 2022, Coffee Holding entered into a merger and share exchange agreement, dated September 29, 2022, with Delta, whereby Coffee Holding and Delta will each become wholly owned subsidiaries of Pubco. The closing of the transactions contemplated by the definitive agreement is subject to certain conditions, including, without limitation, the approval of the stockholders of Coffee Holding and the approval of the listing of the ordinary shares of Pubco on the Nasdaq Stock Market. Delta shareholders will become the majority shareholders of Pubco following these transactions.

08:05 EDT Clene announces publication on CNM-Au8 catalytic mechanism of action - Clene announced the publication of a scientific paper describing the catalytic mechanism of action of its investigational drug CNM-Au8(R) in the journal Small, a top nanotechnology-focused journal at the interface of materials science, chemistry, physics, engineering, medicine, and biology. The publication, titled "A Mechanism Underpinning the Bioenergetic Metabolism-Regulating Function of Gold Nanocatalysts," is co-authored by lead investigators at the University of South Carolina and Clene. This study demonstrates that the robust neuroprotective properties of CNM-Au8 can be attributed to its therapeutic catalytic activity. When neurons were exposed to toxins that induce neuronal death, CNM-Au8 treatment promoted the survival of cells and preservation of neurite networks. To unravel the mechanisms underpinning the neuroprotective function of CNM-Au8, Professor Hui Wang, Ph.D., and his graduate students at the University of South Carolina conducted detailed studies focused on characterizing CNM-Au8-mediated catalytic reactions to determine how CNM-Au8 effectively regulates cellular health and metabolism. Neuronal deficiencies have been associated with cell death in multiple types of neurodegenerative disease, as documented by a growing body of scientific literature. Because of the unique mechanism of CNM-Au8 and the wide applicability of its neuroprotective activities, Clene's lead asset is being investigated in the clinic as a potential first-in-class drug for the treatment of multiple neurodegenerative diseases, including amyotrophic lateral sclerosis, multiple sclerosis and Parkinson's disease.

08:03 EDT Shift4 Payments, Amazon collaborate to deliver checkout-free shopping - Shift4 (FOUR) announced it has implemented its VenueNext solution with Amazon's (AMZN) Just Walk Out technology for a shopping experience for fans. Customers can use this solution at the United Center in Chicago, which is expanding from three stores powered by Just Walk Out technology to seven, enabled by Shift4's VenueNext solution. Shopping at a location powered by Amazon's Just Walk Out technology is designed to be an effortless experience. When entering the store, customers simply scan the venue's mobile wallet, powered by Shift4's VenueNext solution. The Just Walk Out technology detects what shoppers take from or return to the shelves and creates a virtual shopping session. When guests complete their shopping, they leave the store without waiting in line, and their VenueNext-powered mobile wallet will be charged for items they take.

08:03 EDT Brixmor names Brian Finnegan as COO - Brixmor Property Group announced that Angela Aman, currently the company's Executive Vice President, CFO and Treasurer, has been promoted to the additional position of President, and Brian Finnegan, currently the company's Executive Vice President, Chief Revenue Officer, has been promoted to Senior Executive Vice President and COO. In her new role, in addition to her current responsibilities, Aman will oversee the company's reinvestment function. In his new role, in addition to his current responsibilities, Finnegan will oversee the company's construction and property management functions.

08:02 EDT PPG partners with Eindhoven University of Technology to develop Stella Terra - PPG announced a partnership with a student organization from the Eindhoven University of Technology in the Netherlands to develop the Stella Terra, believed to be the world's first off-road car powered by the energy of the sun, making it independent of charging stations and paved roads. PPG is providing a grant of $37,000 to the Solar Team Eindhoven

08:01 EDT Akebia resubmits New Drug Application to the FDA for vadadustat - Akebia has resubmitted its New Drug Application to the FDA for vadadustat, Akebia's investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. Vadadustat is currently approved for use in 35 countries. A letter from the FDA acknowledging that the resubmission is complete, classifying the resubmission, and setting the PDUFA date is expected in 30 days. Akebia expects the FDA to set a PDUFA date of six months from the date of submission.

07:57 EDT Fairfax Financial announces intention to make normal course issuer bid - Fairfax Financial Holdings announces that the Toronto Stock Exchange has accepted a notice filed by Fairfax of its intention to commence a Normal Course Issuer Bid through the facilities of the TSX for its Subordinate Voting Shares and the following series of its Preferred Shares: Cumulative 5-Year Rate Reset Preferred Shares, Series C, Cumulative Floating Rate Preferred Shares, Series D, Cumulative 5-Year Rate Reset Preferred Shares, Series E, Cumulative Floating Rate Preferred Shares, Series F, Cumulative 5-Year Rate Reset Preferred Shares, Series G, Cumulative Floating Rate Preferred Shares, Series H, Cumulative 5-Year Rate Reset Preferred Shares, Series I, Cumulative Floating Rate Preferred Shares, Series J Cumulative 5-Year Rate Reset Preferred Shares, Series K and Cumulative 5-Year Rate Reset Preferred Shares, Series M. Purchases will be made in accordance with the rules and policies of the TSX. Subordinate Voting Shares purchased will be either cancelled or reserved for share-based payment awards and Preferred Shares purchased will be cancelled.

07:55 EDT Stack Capital holding Hopper enters partnerships with Hotelbeds, WebBeds - Stack Capital Group announced that Hopper has entered into strategic partnerships with Hotelbeds and WebBeds. As the third largest online travel agency in the United States, with 100+ million app downloads, these new partnerships allow Hopper to 'super-charge' its efforts to build the best-in-class global hotel supply network, benefitting both its app users along with the impressive list of Hopper Cloud partners and their respective clients.

07:48 EDT PureTech Health notes Karuna Therapeutics submits KarXT NDA to FDA - PureTech Health noted that its Founded Entity, Karuna Therapeutics announced the submission of a new drug application, or NDA, to the FDA for KarXT for the treatment of schizophrenia.

07:38 EDT Bowman Consulting awarded $700,000 contract with Canadian National - Bowman Consulting (BWMN) announced it has been awarded a multi-year, on-call engineering services contract with the Canadian National (CNI). Under the contract, Bowman will provide as-needed engineering and design work at various CN locations throughout the United States. These services include railway bridge design, railway track design, project management/construction management, civil and structural engineering design, drainage, stormwater management, transportation engineering, wastewater treatment, field surveys, GID/CADD and hydrology. The first task order under the contract is a $700,000 construction management services assignment relating to a project in the suburban Chicago area. The project entails the construction of sheet pile retaining walls, excavation, embankment work and the replacement of the current stormwater management system for the construction of a secondary mainline track and accompanying support structures. Additionally, the project involves the installation of proposed lift stations and widening an existing bridge structure that spans a major roadway.

07:36 EDT ARway.ai completes first build of ARway platform on Apple's Vision Pro - ARway.ai announced significant enhancements to its platform and technology. ARway V2.5 was a transformative update that introduced AI-assisted pathfinding, engaging path styles, and advanced creator tools. This new 2.6 version builds upon these features, offering even more advanced capabilities such as multi-map and multi-floor navigation capabilities on the Web Creator Portal, a comprehensive location directory and improved onboarding experience, ensuring ARway's technology remains at the forefront of the Augmented Reality industry. The significance of these upgrades cannot be overstated. In a world where AR technology is increasingly intertwined with various industries, from retail and hospitality to corporate sectors, ARway's enhanced platform meets the growing demand for precise and reliable AR experiences. ARway is pleased to report that at the developer labs, the Company completed a first build of the ARway Platform on Apple's Vision Pro hardware and realityOS operating system at Apple Park, Cupertino where developers got exclusive access to early prototypes of the headsets.

07:35 EDT Jabil increases share repurchase program to $2.5B - The board of directors has amended and increased the current share repurchase program, which has approximately $776M outstanding as of August 31 to allow repurchase of up to $2.5B in common stock. The shares will be repurchased from time-to-time using various methods, including in the open market at the Company's discretion and subject to market conditions and other factors.

07:34 EDT Cytokinetics announces call for proposals for Communications Grant Program - Cytokinetics announced a call for proposals for the sixth annual Cytokinetics Communications Grant Program. The program will award five grants in the amount of $20,000 each to patient advocacy organizations serving the hypertrophic cardiomyopathy, heart failure and amyotrophic lateral sclerosis communities. The grants are intended to support increased capacity in communications, awareness building and community engagement.

07:32 EDT mdf Commerce enters agreement with Texas Comptroller of Public Accounts - mdf commerce announces that the Texas Comptroller of Public Accounts has signed an agreement for its Statewide Procurement Division to use the company's source-to-contract suite of solutions, which includes a supplier portal for reconciliation and payment of convenience fees, an important need for the office. This initiative will power the SPD's contract development, supplier relationship and contract management processes. It will play a critical role in the integration between our source-to-contract solution and both the Electronic State Business Daily an online application of the Texas SmartBuy website where agencies post bid opportunities and awards, and the Centralized Master Bidders List, the state's global suppliers' directory.

07:21 EDT Sunnova Energy enters $3B partial loan guarantee agreement with DOE - Sunnova Energy announced it has entered into a $3B partial loan guarantee agreement with the U.S. Department of Energy, or DOE, Loan Programs Office, or LPO, which equates to a 90% guarantee of up to $3.3B of term loans, to support solar loans originated by Sunnova under a new solar loan channel named "Project Hestia."

07:19 EDT NioCorp to produce U.S.-made scandium master alloy for vehicle parts - NioCorp Developments plans to make aluminum-scandium master alloy product from mining and upgrade facilities to be located in the U.S., subject to, among other matters, receipt of project financing and consummation of mining operations at the Elk Creek Project, which could enable commercial and defense manufacturers to replace select existing aluminum parts in vehicles. Aluminum alloys containing scandium offer high-strength, corrosion-resistant, weldable alternatives to existing aluminum options and deliver significant property improvements and light-weighting opportunities, particularly in transportation applications. Military and strategic applications are expected to be significant as well. Scandium is one of several strategic metal products that NioCorp plans to make from its Elk Creek Critical Minerals Project in Nebraska, USA, contingent on, among other matters, obtaining sufficient project financing. Once in commercial operation, the scandium component from this mine could potentially position NioCorp as one of the largest producers of Al-Sc MA in the world. Still, more scandium production would need to come online in both North America and Europe, if more than a small handful of manufacturers are to benefit from these high-performance aluminum alloy variants.

07:16 EDT Nitches, Inc. partners with bottle manufacturer Joco Glass - Nitches announced a new partnership with a luxury bottle manufacturer based in Mexico. The company said, "The luxury bottle manufacturer, Joco Glass, renowned for its passion for quality, shares Nitches Corp's passion for craftsmanship and quality. Together, these two industry leaders will co-create an exclusive line of luxury bottles designed to meet the expectation of quality that everyone has grown to expect from Nitches Products setting Tover Spirits apart from the competition."

07:13 EDT ImmunoGen announces findings from MIRASOL trial - ImmunoGen announced findings from two subset analyses of the Phase 3 confirmatory MIRASOL trial evaluating the safety and efficacy of Elahere compared to chemotherapy in patients with folate receptor alpha, or FRa-positive platinum-resistant ovarian cancer, or PROC. The findings will be presented by Toon Van Gorp in an oral presentation at the 24th Congress of the European Society of Gynaecological Oncology, or ESGO, in Istanbul, Turkey. In addition to the top-line MIRASOL data previously disclosed and subsequently presented at the 2023 American Society of Clinical Oncology, or ASCO, annual meeting, the following new data are being presented at ESGO: Elahere demonstrated clinically meaningful improvement in PFS and ORR by investigator assessment and in OS compared to IC chemotherapy, regardless of prior PARPi exposure. In patients with prior PARPi, PFS hazard ratio was 0.58; in the PARPi-naive subset, PFS HR was 0.74. In patients with prior PARPi, ORR in the Elahere arm was 45%, including 7 CRs, compared to 17%, with no CRs, in the IC chemotherapy arm; in the PARPi-naive subset, ORR in the Elahere arm was 40%, including 5 CRs, compared to 14%, with no CRs, in the IC chemotherapy arm. In patients with prior PARPi, OS HR was 0.48; in the PARPi-naive subset, OS HR was 0.90. Elahere demonstrated clinically meaningful improvements in PFS and ORR by investigator assessment and in OS compared to IC chemotherapy, regardless of prior lines of therapy. In patients with 1 or 2 PLOT, the PFS HR was 0.61; in patients with 3 PLOT, PFS HR was 0.71. In patients with 1 or 2 PLOT, ORR in the ELAHERE arm was 46% (95% CI: 37%, 55%), including 10 complete responses, or CRs, compared to 15%, with no CRs, in the IC chemotherapy arm; in patients with 3 PLOT, ORR in the ELAHERE arm was 38%, including two CRs, compared to 18%, with no CRs, in the IC chemotherapy arm. In patients with 1 or 2 PLOT, OS HR was 0.66; in patients with 3 PLOT, OS HR was 0.65. Elahere demonstrated a tolerable safety profile compared to IC chemotherapy consisting predominantly of low-grade ocular and gastrointestinal events. In all patients, the frequency of grade 3+ treatment-emergent adverse events, or TEAEs, was 42% with Elahere and 54% with IC chemotherapy; the frequency of serious adverse events, or SAEs, was 24% with Elahere and 33% with IC chemotherapy; and the frequency of discontinuations due to a TEAE was 9% with Elahere and 16% with IC chemotherapy.

07:10 EDT GXO Logistics appoints Veekens as Managing Director for Belgium, Netherlands - GXO Logistics announced that it has hired European contract logistics veteran Willem Veekens as Managing Director for its operations in Belgium and the Netherlands. Immediately prior to joining GXO, Veekens served as Managing Director - Belgium, Netherlands and Luxembourg for CEVA Logistics, where he had also held several senior director roles.

07:09 EDT OTC Markets Group welcomes Telenor to OTCQX - OTC Markets Group announced Telenor ASA has qualified to trade on the OTCQX Best Market. Telenor ASA upgraded to OTCQX from the Pink market.

07:08 EDT Ecarx, SiEngine, XINGJI announce first delivery of CARX Antora 1000 Pro - ECARX together with SiEngine and XINGJI MEIZU Group held a production delivery ceremony on 26 September at Lynk & Co's Yuyao plant, and, at the same time, at Hubei Dongjun Automotive Electronics Technology. The joint production team thus celebrated the successful first delivery of the ECARX Antora 1000 Pro digital cockpit computing platform for the Lynk & Co 08 SUV. During the delivery ceremony, Rongbo Zhang, Senior Vice President of Product Development at ECARX China, Chongjun Zhang, Chairman of Hubei Dongjun Industry Group and Hubei Dongjun Automotive Electronics Technology, together with other executives of the joint production team, visited the highly automated and dust-free production line. As a token, the Wuhan team gifted a set of mass-produced ECARX Antora products to the joint project representatives, thus celebrating the high quality mass production of the Lynk & Co 08.

07:06 EDT Canada Goose announces Marjan Anwar Khan as CTO - Canada Goose (GOOS) announced the appointments of Gary Saage, former group CFO, Richemont, and Jennifer Davis, Partner, Bain Capital Private Equity, to the Canada Goose board of directors, effective immediately. Davis will replace Josh Bekenstein, who has made the decision to resign from the board. Saage will also join the audit committee. At the same time, Canada Goose announced that Marjan Anwar Khan will join the company as chief technology officer. Before joining Canada Goose, Marjan spent eight years at Restaurant Brands International (QSR).

07:05 EDT Mobilicom awarded $250,000 grant from Space Florida - Mobilicom announced it was awarded a new grant of approximately $250,000 from Space Florida, Florida's Aerospace, Finance and Development Authority. This grant renews Mobilicom's contract for another year. Mobilicom is developing a Multi-Link communications system that incorporates three concurrent transmitting transceivers for auto redundancy to address U.S. civil drone regulations. "Following our very successful and productive collaboration with Space Florida over the past year, this new grant underscores the value that Mobilicom brings to the innovation process in the rapidly evolving drone industry. Our SkyHopper Datalinks already support line-of-sight and cellular network-based 'beyond-line-of-sight' communication. By integrating satellite connectivity, Mobilicom is creating additional redundancy to address market needs for long-range drone delivery and inspection operations with 'always-connected-anywhere' capability," stated Mobilicom CEO Oren Elkayam.

07:04 EDT Myriad Genetics survey shows breast cancer risk factors are misunderstood - Myriad Genetics announced results from a nationwide survey revealing breast density and family health history are two misunderstood breast cancer risk factors. The Myriad Genetics Cancer Risk Survey found that nearly half of the women surveyed do not know what breast density is, and 50% are unsure if breast density has anything to do with breast cancer risk. Women with dense breasts are up to four times more likely to develop breast cancer compared to women without dense breasts. In addition, higher-density tissue can make it more difficult to detect breast masses or cancer during a mammogram and may require additional imaging tests. The Federal Drug Administration recently updated mammography regulations, requiring mammography facilities to notify patients about the density of their breasts by September 2024. Additionally, few women feel like they have all the medical information they need from their mother's side and father's side to better understand their breast cancer risk. "Our survey revealed there is critical work that needs to be done to help women better understand how family history and breast density, in addition to other key factors, play into their overall breast cancer risk," said Melissa Gonzales, President of Women's Health, Myriad Genetics. "Having open conversations with your family and OB-GYN, and getting annual mammograms, are essential in breaking down these critical awareness gaps and staying on top of your breast health. For women with elevated risk factors, genetic testing can be a helpful tool that provides a cancer risk assessment personalized to them."

07:03 EDT Alta Equipment Group to acquire Burris Equipment for $14M in cash - Alta Equipment Group announced that it has entered into a definitive agreement to acquire Burris Equipment Company. Strategic and Financial Highlights: Diversifies product portfolio and end markets in the Chicago area and expands Alta's infrastructure in the region with three new branches in Joliet, Waukegan and Lakemoor. Burris generated approximately $40.6 million in revenue for the trailing twelve-month period through July 2023. Deal is structured as an asset acquisition allowing for step-up in tax basis of assets acquired. Additional Transaction Details: The purchase price is $14.0 million in cash, subject to working capital adjustments. The transaction is subject to customary closing conditions and is expected to close in the fourth quarter of 2023. Including Burris, since the Company's initial public offering in 2020, Alta has completed 15 acquisitions which have contributed $487 million in revenue, and $58 million in Adjusted EBITDA. More information on Burris, its products and applications can be found at https://burrisequipment.com/home.

06:54 EDT CarMax intends to resume share repurchases in Q3 of this year

06:49 EDT Accenture sees FY24 operating cash flow $9.3B-$9.9B - For fiscal 2024, the company expects operating cash flow to be in the range of $9.3 billion to $9.9 billion; property and equipment additions to be $600 million; and free cash flow to be in the range of $8.7 billion to $9.3 billion. The company expects to return at least $7.7 billion in cash to shareholders through dividends and share repurchases.

06:47 EDT Accenture raises quarterly dividend 15% to $1.29 per share - Accenture plc has declared a quarterly cash dividend of $1.29 per share, for shareholders of record at the close of business on October 12, 2023. This dividend, which is payable on November 15, 2023, represents a 15% increase over the company's previous quarterly dividend.

06:37 EDT Caesars' Sportsbook betting app goes live on mobile and desktop in Kentucky - Caesars Entertainment's flagship sports wagering app, Caesars Sportsbook, is now available on mobile and desktop in Kentucky. Caesars Sportsbook ties sports betting to rewards via the customer loyalty program, Caesars Rewards. On Sept. 7, Caesars celebrated its grand opening of Caesars Sportsbook at Red Mile Gaming & Racing in Lexington through its partnership with Keeneland and Red Mile.

06:32 EDT Nxu Inc. launches EV charging field trials in Arizona - Nxu Inc. has launched its first public EV charging field trials, in Mesa, Ariz. EV users can charge their vehicles, of any make or model that supports CCS, 24 hours a day. Sept. 28-Oct. 1, all charges cost $1. The Nxu One Charging System is the only universal, dual-technology solution available for public charging. Nxu recently announced its plans to secure a permanent charging location in Quartzsite, Ariz.

06:24 EDT Stada, Calliditas submit EMA request to convert Kinpeygo marketing authorization - Partners Stada and Calliditas Therapeutics announced the submission of a request to the European Medicines Agency, or EMA, for the Committee for Medicinal Products for Human Use, or CHMP, to convert the conditional marketing authorization for Kinpeygo, their treatment for primary IgA nephropathy, or IgAN, to standard, or "full", marketing authorization. Kinpeygo is currently approved under conditional approval to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression with a urine protein-to-creatinine ratio of 1.5 g/gram. This was granted in the interest of public health because the medicine addresses an unmet medical need, and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required.

06:03 EDT Bionomics reports 'positive' results from Phase 2b ATTUNE trial of BNC210 - Bionomics announced positive topline results from its Phase 2b ATTUNE trial of BNC210 for the treatment of PTSD, as described more fully below. ATTUNE is a double-blind, placebo-controlled Phase 2b trial conducted in a total of 34 sites in the United States and the United Kingdom, with 212 enrolled patients, randomized 1:1 to receive either twice daily 900 mg BNC210 as a monotherapy or placebo for 12 weeks. The trial met its primary endpoint of change in Clinician-Administered PTSD Scale for DSM-5 total symptom severity score from baseline to Week 12. A statistically significant change in CAPS-5 score was also observed at Week 4 and at Week 8. Treatment with BNC210 also showed statistically significant improvement both in clinician-administered and patient self-reporting in two of the secondary endpoints of the trial. Specifically, BNC210 led to significant improvements at Week 12 in depressive symptoms and sleep as measured by Montgomery-Asberg Depression Rating Scale and Insomnia Severity Index, respectively. BNC210 also showed signals and trends across visits in the other secondary endpoints including the clinician and patient global impression - symptom severity and the Sheehan Disability Scale. Additionally, the company recently held what it believes was a successful, Phase 3-enabling End-of-Phase 2 meeting with the FDA for the advancement of BNC210 for the acute treatment of social anxiety disorder into registrational studies and is awaiting receipt of the formal meeting minutes.

06:02 EDT FanDuel now available in Kentucky - FanDuel is now available across Kentucky. Mobile sports betting will open at 6 a.m. ET, and sports fans in Kentucky can download the FanDuel Sportsbook app for iOS and Android or play via desktop.

05:34 EDT Mirion announces Sun Nuclear achieves CE mark for SunSCAN 3D - Sun Nuclear, a Mirion Medical company, announced achievement of the CE mark per EU Medical Device Regulation for the SunSCAN 3D cylindrical water scanning system. The SunSCAN 3D system supports linear accelerator commissioning, beam scanning and annual Quality Assurance in Radiation Therapy. Since its release in May 2022, the SunSCAN 3D system has found widespread clinical adoption in countries outside of those requiring the CE mark for its efficiency and hyper-accuracy. Through a rigorous regulatory review and approval process, the SunSCAN 3D system is now available for sale in countries that require CE marking.

05:15 EDT Interactive Brokers announces consolidation of European brokerage operations - Interactive Brokers announced the consolidation of its European brokerage operations, with Interactive Brokers Central Europe, or IBCE, based in Budapest Hungary, merging its client base and operations into the operations of Interactive Brokers Ireland, or IBIE. The Group expects the merger of its European operations to produce measurable improvements in efficiency, while retaining its key talent pool and regional client focus. IB Ireland, based in Dublin and regulated by the Central Bank of Ireland, will manage the merged business, with IBCE continuing to provide its expertise to clients across the continent, and particularly in Central and Eastern Europe. Since commencing business following Brexit, these two operations have delivered and supported significant client growth as Interactive Brokers Group expands its presence across Europe.

05:06 EDT Figs, Everton Football Club enter multi-faceted partnership - Everton Football Club and Figs announced that they have entered into a multi-faceted partnership to support the Club's healthcare professionals and those in the surrounding community. The partnership between Everton and FIGS extends both on and off the pitch. Figs will supply technical apparel specifically designed for the medical teams of the Blues' men's and women's senior squads. Figs branding also will be present at Everton's Goodison Park matches, as it was during the Club's match against Arsenal earlier this month. In addition, the men's senior team medical staff started wearing custom FIGS apparel at Everton's most recent two Premier League fixtures.